NanoString
Business Services · Washington, United States · 501-1,000 Employees
View Company Info for Free
Overview
Headquarters
530 Fairview Ave N, Seattle, Washington,...Phone Number
(206) 378-6266Website
www.nanostring.comRevenue
$162.5 MillionStock Symbol
NSTGIndustry
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
2
2
1
2
1
1
About NanoString
NanoString Technologies is a provider of life science tools for translational research. The company was founded in 2003 and is located in Seattle, Washington.Explore more
NanoString Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is NanoString your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Congratulate Masked Content for being promoted to Masked Content at NanoString
Product Launch: Get notified when NanoString launches new products
Earning: See what the market has to say on NanoString recently announced quarterly report
Check out if NanoString is spiking on competitors!
Check if NanoString has recently received funding, and reach out quickly before it becomes old news!
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Website visits: Recent activity has been detected on your website
Click to see if NanoString had a recent Job posting/layoffs
Funding: Get notified immidiatlly once NanoString has new funding data
NanoString, which may be a good buyer, showed buying intent in Masked Content Topic
Recommended Actions
Find VP level buyers at NanoString
Find 2 more new buyers
Compare Similar Companies to NanoString
Compare insights from companies similar to NanoString, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
NanoString
$162.5M
501-1,000
Public
$983.4M
2003
JB
Jonathan BunnellHead Executive VP, Global Government Affairs
$60.1M
51-200
Private
$82M
2006
DV
Daniel VummagoniCorporate Development Senior VP & Chief Financial Officer
Company Profile Activity
Activity Insights
NanoString is experiencing very low activity levels compared to other companies in the Business Services sector.
What does this means?
NanoString is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about NanoString.
NanoString financials insights
Gather financial insights about NanoString, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2013
Stock Offering
$54M
2014
Stock Offering
$57M
Debt
$45M
2017
Stock Offering
$56.5M
2018
Stock Offering
$46.8M
Debt
$100M
2019
Stock Offering
$68.3M
2020
Debt
$200M
Stock Offering
$215.7M
2024
Other Financing Round
$47.5M
NanoString Tech Stack
A closer look at the technologies used by NanoString
Most Recent Scoops
Left Company
Executive Move
Executive Moves, Left Company
Mergers & Acquisitions (M&A)
Mergers & Acquisitions
Mergers & Acquisitions (M&A)
Funding
Pain Point
Pain Point, Bankruptcy, Intellectual Property, Legal Affairs
NanoString News & Media
U.S. District Court Awards 10x Genomics Permanent Injunction in Patent Infringement Lawsuit Against Bruker Corporation's GeoMx Products
PLEASANTON, Calif., Dec. 23, 2024 /PRNewswire/ -- 10x Genomics, Inc. (Nasdaq: TXG), a leader in single cell and spatial biology, announced today it had secured a permanent injunction in the U.S. District Court for the District of Delaware against the GeoMx products sold by Bruker...European Unified Patent Court Rules in Favor of Bruker and NanoString, Invalidating Patent Asserted By 10x Genomics against NanoString’s CosMx SMI Products
BILLERCA, Mass.--(BUSINESS WIRE)---- $BRKR #BRKR--Bruker Corporation (Nasdaq: BRKR) today announced that the European Unified Patent Court (UPC) has ruled in favor of its NanoString business, invalidating European Patent No. 2794928B1 (the “928 Patent”), which has been asserted by 10x Genomics against NanoString’s CosMx® Spatial Molecular Imager (SMI) products in Europe. Today’s ruling follows the May 2024 decision of the German Federal Patent Court, which declared the 928 Patent invalid and revBruker Unveils Spatial Strategy Post NanoString Acquisition
Mark Munch, president of Bruker Nano Group, talks to GEN about Bruker’s reasons for acquiring Nanostring and their vision for the future.Bruker Announces that Injunction Impacting NanoString’s CosMx Spatial Molecular Imager Products in Germany Has Been Suspended Effective Immediately
BILLERICA, Mass.--(BUSINESS WIRE)---- $BRKR #BRKR--Bruker Corporation (Nasdaq: BRKR) today announced that it has posted a bond, as authorized by the Munich Higher Regional Court, in order to suspend an injunction that had been impacting sales of CosMx™ Spatial Molecular Imager (SMI) products by its NanoString business in Germany. This development is connected with ongoing patent litigation with 10x Genomics, during an appeal process in Germany. Effective immediately, all CosMx products are once
Read more news
Top Business Services Companies
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding NanoString
Sign Up For FreeTo access detailed company insights
NanoString Technologies is a provider of life science tools for translational research. The company was founded in 2003 and is located in Seattle, Washington.... Read More
